Researchers have found a way to tame pancreatic cancer - one of the most aggressive and difficult to treat cancers - by delivering immunotherapy directly into the tumour with a device that is smaller than a grain of rice.
An enzyme that protects human cells against viruses can help drive cancer evolution towards greater malignancy by causing myriad mutations in cancer cells, a new study has shown.
The new results show that metastatic tumours suppress the activity of a key enzyme in propionate metabolism, the process by which cells digest certain fatty acids and protein components.
Rajiv Gandhi Cancer Institute & Research Centre (RGCIRC) organised a Neuro & Spine Onco Update at RGCIRC Rohini Delhi.
The oral NLRP3 inhibitor used in the study (Dapansutrile) has already shown to be effective in clinical trials to treat gout and heart disease, and it is currently being tested in Covid-19 as well.
Western high-fat diet can make prostate cancer grow more aggressive.
Cancer tumours manipulate a natural cell process to promote their survival and controlling this may help stop progress of the…
